Skip to main content
. 2022 May 9;12:7612. doi: 10.1038/s41598-022-11788-3

Table 4.

Clinical and imaging outcomes at 1-month follow-up according to TAVI-CT (transcatheter aortic valve implantation-computed tomography) score.

Feature Low score (0–2) Intermediate score (3) High score (≥ 4) p value
Patients 74 50 76
Total length of stay (days) 5.4 ± 1.9 5.7 ± 1.8 5.9 ± 2.2 0.329
Major adverse event* 2 (2.7%) 3 (6.0%) 6 (7.9%) 0.390
Death 1 (1.4%) 1 (2.0%) 1 (1.3%) 1
Cardiac death 1 (1.4%) 0 1 (1.3%) 1
Myocardial infarction 1 (1.4%) 1 (2.0%) 0 0.526
Stroke 0 1 (2.0%) 0 0.250
Bleeding 0.469
None 74 (100%) 49 (98%) 74 (97.4%)
Type 1 0 1 (2.0%) 2 (2.6%)
Type 2 0 0 0
Type 3 0 0 0
Type 4 0 0 0
Vascular complication 0.041
None 74 (100%) 50 (100%) 72 (94.7%)
Minor 0 0 4 (5.3%)
Major 0 0 0
Surgical conversion 0 0 0 1
Aortic dissection 0 0 0 1
Anulus rupture 0 0 0 1
Bailout percutaneous coronary intervention 1 (1.4%) 1 (2.0%) 0 0.526
Permanent pacemaker implantation 6 (8.1%) 6 (12.0%) 10 (13.2%) 0.599
Left ventricular ejection fraction (%) 52.7 ± 8.0 52.1 ± 9.3 52.3 ± 8.9 0.902
Peak gradient (mm Hg) 13.9 ± 5.1 13.5 ± 5.6 13.9 ± 6.1 0.888
Mean gradient (mm Hg) 7.9 ± 3.2 7.6 ± 3.5 7.9 ± 3.5 0.830
Aortic regurgitation 0.113
None 15 (20.6%) 5 (10.0%) 15 (19.7%)
1+ 55 (75.3%) 44 (88.0%) 53 (69.7%)
2+ 3 (4.1%) 1 (2.0%) 8 (10.5%)

*Composite of death, myocardial infarction, stroke, bleeding, or vascular complication.